The role of TLR2 and 4-mediated inflammatory pathways in endothelial cells exposed to high glucose

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Mudaliar, Harshini ^a   Pollock, Carol ^a   Ma, Jin ^b   Wu, Huiling ^b   Chadban, Steven ^b   Panchapakesan, Usha ^a  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; RECOMBINANT PROTEIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAPILLARY ENDOTHELIAL CELL; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPOSURE; GEL MOBILITY SHIFT ASSAY; HMEC 1 CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INFLAMMATION; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; SUPERNATANT; UPREGULATION; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; CELL LINE; EXPERIMENTAL DIABETES MELLITUS; GENE DELETION; GENETICS; IMMUNOLOGY; PATHOLOGY;

ANIMALS; CELL LINE; DIABETES MELLITUS, EXPERIMENTAL; ENDOTHELIAL CELLS; GENE DELETION; GLUCOSE; HUMANS; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; MICE, INBRED BALB C; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

EID: 84907833448     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0108844     Document Type: Article

References (45)

1. Ceriello A (2008) The management of post-prandial glucose. US Endocrinology. 63-66 p.
2. American Diabetes Association (2001) Postprandial Blood Glucose. Diabetes Care 24: 775-778.
3. UK Prospective Diabetes Study (UKPDS) Group (1998). Intensive bloodglucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352: 837-853.
4. Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, et al. (1995) Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 28: 103-117.
5. The Diabetes Control and Complications Trial Research Group (1993). The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977-986.
6. Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, et al. (2012) Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach: Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 35: 1364-1379.
7. Gluba A, Banach M, Hannam S, Mikhailidis DP, Sakowicz A, et al. (2010) The role of Toll-like receptors in renal diseases. Nat Rev Nephrol 6: 224-235.
8. Takeda K, Akira S (2005) Toll-like receptors in innate immunity. International Immunology 17: 1-14.
9. Kawai T, Akira S (2006) TLR signaling. Cell Death Differ 13: 816-825.
10. Shichiri M, Kishikawa H, Ohkubo Y, Wake N (2000) Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients. Diabetes Care 23: B21-29.
11. Kawano H, Motoyama T, Hirashima O, Hirai N, Miyao Y, et al. (1999) Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery. J Am Coll Cardiol 34: 146-154.
12. Ceriello A, Quagliaro L, Piconi L, Assaloni R, Da Ros R, et al. (2004) Effect of postprandial hypertriglyceridemia and hyperglycemia on circulating adhesion molecules and oxidative stress generation and the possible role of simvastatin treatment. Diabetes 53: 701-710.
13. Azuma K, Kawamori R, Toyofuku Y, Kitahara Y, Sato F, et al. (2006) Repetitive fluctuations in blood glucose enhance monocyte adhesion to the endothelium of rat thoracic aorta. Arterioscler Thromb Vasc Biol 26: 2275-2280.
14. Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, et al. (2002) Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 106: 2067-2072.
15. Morioka T, Emoto M, Tabata T, Shoji T, Tahara H, et al. (2001) Glycemic control is a predictor of survival for diabetic patients on hemodialysis. Diabetes Care 24: 909-913.
16. Stehouwer CDA (2004) Endothelial dysfunction in diabetic nephropathy: state of the art and potential significance for non-diabetic renal disease. Nephrol Dial Transplant 19: 778-781.
17. Taslipinar A, Yaman H, Yilmaz M, Demirbas S, Saglam M, et al. (2011) The relationship between inflammation, endothelial dysfunction and proteinuria in patients with diabetic nephropathy. Scand J Clin Lab Invest 71: 606-612.
18. Rudofsky G, Reismann P, Witte S, Humpert PM, Isermann B, et al. (2004) Asp299Gly and Thr399Ile Genotypes of the TLR4 Gene Are Associated With a Reduced Prevalence of Diabetic Neuropathy in Patients With Type 2 Diabetes. Diabetes Care 27: 179-183.
19. Takata S, Sawa Y, Uchiyama T, Ishikawa H (2013) Expression of Toll-Like Receptor 4 in Glomerular Endothelial Cells under Diabetic Conditions. Acta Histochem Cytochem 46: 35-42.
20. Devaraj S, Jialal I, Yun JM, Bremer A (2011) Demonstration of increased tolllike receptor 2 and toll-like receptor 4 expression in monocytes of type 1 diabetes mellitus patients with microvascular complications. Metabolism 60: 256-259.
21. Kawai T, Akira S (2010) The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 11: 373-384.
22. Zarember K, Godowski P (2002) Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNA in leukocytes in response to microbes, their products and cytokines. J Immunol 168: 554-561.
23. Mullins GE, Sunden-Cullberg J, Johansson AS, Rouhiainen A, Erlandsson- Harris H, et al. (2004) Activation of human umbilical vein endothelial cells leads to relocation and release of high-mobility group box chromosomal protein 1. Scand J Immunol 60: 566-573.
24. Fiuza C, Bustin M, Talwar S, Tropea M, Gerstenberger E, et al. (2003) Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. Blood 101: 2652-2660.
25. Ades EW, Candal FJ, Swerlick RA, George VG, Summers S, et al. (1992) HMEC-1: Establishment of an Immortalized Human Microvascular Endothelial Cell Line. J Investig Dermatol 99: 683-690.
26. Skrha Jr, Kalousova M, Svarcova J, Muravska A, Kvasnicka J, et al. (2012) Relationship of soluble RAGE and RAGE ligands HMGB1 and EN-RAGE to endothelial dysfunction in type 1 and type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes 120: 277-281.
27. Yang J, Huang C, Jiang H, Ding J (2010) Statins attenuate high mobility group box-1 protein induced vascular endothelial activation: a key role for TLR4/NFkappaB signaling pathway. Mol Cell Biochem 345: 189-195.
28. Park JS, Gamboni-Robertson F, He Q, Svetkauskaite D, Kim JY, et al. (2006) High mobility group box 1 protein interacts with multiple Toll-like receptors. Am J Physiol Cell Physiol 290: C917-C924.
29. Paulis L, Jacobs I, van den Akker N, Geelen T, Molin D, et al. (2012) Targeting of ICAM-1 on vascular endothelium under static and shear stress conditions using a liposomal Gd-based MRI contrast agent. Journal of Nanobiotechnology 10: 25.
30. Li J, Jin C, Cleveland Jr, Ao L, Xu D, et al. (2010) Enhanced inflammatory responses to toll-like receptor 2/4 stimulation in type 1 diabetic coronary artery endothelial cells: the effect of insulin. Cardiovasc Diabetol 9: 90.
31. Panchapakesan U, Sumual S, Pollock CA, Chen X (2005) PPARgamma agonists exert antifibrotic effects in renal tubular cells exposed to high glucose. Am J Physiol Renal Physiol 289.
32. Zafiriou S, Stanners SR, Polhill TS, Poronnik P, Pollock CA (2004) Pioglitazone increases renal tubular cell albumin uptake but limits proinflammatory and fibrotic responses. Kidney Int 65: 1647-1653.
33. Hak AE, Pols HA, Stehouwer CD, Meijer J, Kiliaan AJ, et al. (2001) Markers of inflammation and cellular adhesion molecules in relation to insulin resistance in nondiabetic elderly: the Rotterdam study. J Clin Endocrinol Metab 86: 4398-4405.
34. Yao D, Brownlee M (2010) Hyperglycemia-Induced Reactive Oxygen Species Increase Expression of the Receptor for Advanced Glycation End Products (RAGE) and RAGE Ligands. Diabetes 59: 249-255.
35. Bae JS, Rezaie AR (2011) Activated protein C inhibits high mobility group box 1 signaling in endothelial cells. Blood 118: 3952-3959.
36. Tuttle K (2005) Linking metabolism and immunology: diabetic nephropathy is an inflammatory disease. J Am Soc Nephrol 16: 5-13.
37. Tang SC, Leung JC, Lai KN (2011) Diabetic tubulopathy: an emerging entity. Contrib Nephrol 170: 124-34.
38. Tang SC, Leung JC, Chan LY, Tsang AW, Lai K (2006) Activation of Tubular Epithelial Cells in Diabetic Nephropathy and the Role of the Peroxisome Proliferator-Activated Receptor-γ Agonist. J Am Soc Nephrol 17: 1633-1643.
39. Gu HF, Ma J, Gu KT, Brismar K (2012) Association of intercellular adhesion molecule 1 (ICAM1) with diabetes and diabetic nephropathy. Front Endocrinol 3: 179.
40. Matsui H, Suzuki M, Tsukuda R, Iida K, Miyasaka M, et al. (1996) Expression of ICAM-1 on glomeruli is associated with progression of diabetic nephropathy in a genetically obese diabetic rat, Wistar fatty. Diabetes Research and Clinical Practice 32: 1-9.
41. Wang JJ, Zhang SX, Mott R, Chen Y, Knapp RR, et al. (2008) Antiinflammatory effects of pigment epithelium-derived factor in diabetic nephropathy. Am J Physiol Renal Physiol 294: F1166-1173.
42. Chow FY, Nikolic-Paterson DJ, Ozols E, Atkins RC, Tesch GH (2005) Intercellular adhesion molecule-1 deficiency is protective against nephropathy in type 2 diabetic db/db mice. J Am Soc Nephrol 16: 1711-1722.
43. Okada S, Shikata K, Matsuda M, Ogawa D, Usui H, et al. (2003) Intercellular Adhesion Molecule-1-Deficient Mice Are Resistant Against Renal Injury After Induction of Diabetes. Diabetes 52: 2586-2593.
44. Kaur H, Chien A, Jialal I (2012) Hyperglycemia induced Toll like receptor 4 Expression and Activity in Mouse Mesangial cells: Relevance to Diabetic Nephropathy. Am J Physiol Renal Physiol 303: F1145-1150.
45. Mudaliar H, Pollock C, Komala MG, Chadban S, Wu H, et al. (2013) The role of Toll-like receptor proteins (TLR) 2 and 4 in mediating inflammation in proximal tubules. Am J Physiol Renal Physiol 305: F143-154.